Healthcare - Biotechnology - NASDAQ - US
$ 1.78
2.3 %
$ 688 M
Market Cap
-0.56
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--
EBIT
Estimate
--
Net Income
Estimate
--
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Humacyte, Inc.
HUMAW has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart HUMAW
HUMAW has no estimates for Revenue Forecast.
EBIT FORECAST
EBIT Forecast Chart HUMAW
HUMAW has no estimates for EBIT Forecast.
NET INCOME FORECAST
Net Income Chart HUMAW
HUMAW has no estimates for Net Income.